Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in Eur J Gastroenterol Hepatol

Retrieve available abstracts of 76 articles:
HTML format
Text format



Single Articles


    May 2017
  1. JABLONKA A, Solbach P, Wobse M, Manns MP, et al
    Seroprevalence of antibodies and antigens against hepatitis A-E viruses in refugees and asylum seekers in Germany in 2015.
    Eur J Gastroenterol Hepatol. 2017 May 10. doi: 10.1097/MEG.0000000000000889.
    PubMed     Text format     Abstract available


  2. HUANG R, Xia J, Liu Y, Zhang Z, et al
    Acoustic radiation force impulse in the diagnosis of liver fibrosis in patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2017 May 3. doi: 10.1097/MEG.0000000000000902.
    PubMed     Text format    


  3. WAHID B, Saleem K, Ali A, Rafique S, et al
    Rising relapse rate in hepatitis C virus type 3a-infected patients against sofosbuvir and ribavirin combination therapy: a Pakistani experience.
    Eur J Gastroenterol Hepatol. 2017 May 3. doi: 10.1097/MEG.0000000000000895.
    PubMed     Text format    


  4. KOHLA MAS, Abbasy M, Abozeid M, El-Abd O, et al
    Assessment of liver fibrosis with acoustic radiation force impulse imaging versus liver histology in patients with chronic hepatitis C: a pilot study.
    Eur J Gastroenterol Hepatol. 2017 May 3. doi: 10.1097/MEG.0000000000000903.
    PubMed     Text format     Abstract available


  5. CHEN D, Luo S, Ben Q, Lu L, et al
    Prevalence of hepatitis B and C and factors for infection and nonimmune in inflammatory bowel disease patients in China.
    Eur J Gastroenterol Hepatol. 2017;29:509-515.
    PubMed     Text format     Abstract available


    April 2017
  6. CORDERO-RUIZ P, Carmona-Soria I, Rodriguez-Tellez M, Caunedo-Alvarez A, et al
    Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon and ribavirin antiviral therapy: clinical and fibrosis impact of treatment response.
    Eur J Gastroenterol Hepatol. 2017 Apr 25. doi: 10.1097/MEG.0000000000000886.
    PubMed     Text format     Abstract available


  7. MARCELLIN F, Protopopescu C, Esterle L, Wittkop L, et al
    Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH).
    Eur J Gastroenterol Hepatol. 2017 Apr 17. doi: 10.1097/MEG.0000000000000883.
    PubMed     Text format     Abstract available


  8. TABERNILLA A, Grandal M, Pernas B, Castro-Iglesias A, et al
    Viral dynamics among hepatitis C virus chronic infected patients during direct-acting antiviral agents therapy: impact for monitoring and optimizing treatment duration.
    Eur J Gastroenterol Hepatol. 2017 Apr 13. doi: 10.1097/MEG.0000000000000882.
    PubMed     Text format     Abstract available


    March 2017
  9. SHERIGAR JM, Gayam V, Khan A, Mukhtar O, et al
    Clinical efficacy and tolerability of direct-acting antivirals in elderly patients with chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2017 Mar 24. doi: 10.1097/MEG.0000000000000871.
    PubMed     Text format     Abstract available


  10. JI F, Tian C, Li Z, Deng H, et al
    Ledipasvir and sofosbuvir combination for hepatitis C virus infection in three patients aged 85 years and older.
    Eur J Gastroenterol Hepatol. 2017 Mar 21. doi: 10.1097/MEG.0000000000000873.
    PubMed     Text format    


  11. MURATORI P, Efe C, Muratori L, Ozaslan E, et al
    Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study.
    Eur J Gastroenterol Hepatol. 2017 Mar 21. doi: 10.1097/MEG.0000000000000870.
    PubMed     Text format     Abstract available


    February 2017
  12. ZHENG YX, Zhou PC, Zhou RR, Fan XG, et al
    The benefit of statins in chronic hepatitis C patients: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2017 Feb 24. doi: 10.1097/MEG.0000000000000867.
    PubMed     Text format     Abstract available


  13. TAVARES RC, Feldner AC, Pinho JR, Uehara SN, et al
    Prevalence of naturally occurring protease inhibitor resistance-associated variants in hemodialysis and renal transplant patients with hepatitis C virus infection.
    Eur J Gastroenterol Hepatol. 2017 Feb 23. doi: 10.1097/MEG.0000000000000866.
    PubMed     Text format     Abstract available


  14. RONCERO C, Littlewood R, Vega P, Martinez-Raga J, et al
    Chronic hepatitis C and individuals with a history of injecting drugs in Spain: population assessment, challenges for successful treatment.
    Eur J Gastroenterol Hepatol. 2017 Feb 22. doi: 10.1097/MEG.0000000000000855.
    PubMed     Text format     Abstract available


  15. SU F, Beste LA, Green PK, Berry K, et al
    Direct-acting antivirals are effective for chronic hepatitis C treatment in elderly patients: a real-world study of 17 487 patients.
    Eur J Gastroenterol Hepatol. 2017 Feb 13. doi: 10.1097/MEG.0000000000000858.
    PubMed     Text format     Abstract available


  16. GAO F, Sun L, Ye X, Liu Y, et al
    Development and validation of a prognostic model for acute-on-chronic hepatitis B liver failure.
    Eur J Gastroenterol Hepatol. 2017 Feb 13. doi: 10.1097/MEG.0000000000000854.
    PubMed     Text format     Abstract available


  17. NORTH CS, Pollio DE, Sims OT, Jain MK, et al
    An effectiveness study of group psychoeducation for hepatitis C patients in community clinics.
    Eur J Gastroenterol Hepatol. 2017 Feb 13. doi: 10.1097/MEG.0000000000000860.
    PubMed     Text format     Abstract available


  18. SILVA MJ, Pereira C, Loureiro R, Balsa C, et al
    Hepatitis C in a Mobile Low-Threshold Methadone Program.
    Eur J Gastroenterol Hepatol. 2017 Feb 1. doi: 10.1097/MEG.0000000000000843.
    PubMed     Text format     Abstract available


  19. OZTURKER C, Karagoz E, Sivrioglu AK, Kara K, et al
    Clinical usefulness and performance of acoustic radiation force impulse in patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2017 Feb 1. doi: 10.1097/MEG.0000000000000842.
    PubMed     Text format     Abstract available


    January 2017
  20. CHEN D, Luo S, Ben Q, Lu L, et al
    Prevalence of hepatitis B and C and factors for infection and nonimmune in inflammatory bowel disease patients in China.
    Eur J Gastroenterol Hepatol. 2017 Jan 21. doi: 10.1097/MEG.0000000000000838.
    PubMed     Text format     Abstract available


  21. THONNES S, Friedel H, Frohlich H
    The number of patients with chronic hepatitis C in times of new therapy options: a retrospective observational study on German health insurance funds data.
    Eur J Gastroenterol Hepatol. 2017 Jan 12. doi: 10.1097/MEG.0000000000000819.
    PubMed     Text format     Abstract available


    December 2016
  22. HUANG SS, Xie DM, Cai YJ, Wu JM, et al
    C-reactive protein-to-albumin ratio is a predictor of hepatitis B virus related decompensated cirrhosis: time-dependent receiver operating characteristics and decision curve analysis.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  23. TOSON EA, Shiha GE, El-Mezayen HA, Samir W, et al
    Noninvasive estimation of liver fibrosis in biopsy-proven hepatitis C virus-infected patients: angiogenic fibrogenic link.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  24. VOULGARIS T, Vlachogiannakos J, Ioannidou P, Papageorgiou MV, et al
    Adherence to follow-up and treatment recommendations in Greek and immigrant patients with chronic hepatitis B in Greece.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  25. ORDIERES C, Navascues CA, Gonzalez-Dieguez ML, Rodriguez M, et al
    Prevalence and epidemiology of hepatitis D among patients with chronic hepatitis B virus infection: a report from Northern Spain.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  26. SELLIER PO, Maylin S, Bercot B, Chopin D, et al
    Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  27. SILVA MJ, Valente J, Capela T, Russo P, et al
    Epidemiology of hepatitis B in Portugal.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  28. LAPI F, Capogrosso Sansone A, Mantarro S, Simonetti M, et al
    Hepatitis C virus infection: opportunities for an earlier detection in primary care.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  29. WALLACE SJ, Webb GW, Madden RG, Dalton HC, et al
    Investigation of liver dysfunction: who should we test for hepatitis E?
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  30. MCEWAN P, Selvapatt N, Brown A, Thursz M, et al
    A clinician's guide to the cost and health benefits of hepatitis C cure assessed from the individual patient perspective.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  31. TURNER BJ, Liang Y, Singal A
    FIB-4 and imaging for measuring fibrosis in hepatitis C virus.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  32. NORDSTROM EM, Keniston A, Baouchi F, Martinez-Camacho A, et al
    Interferon-based hepatitis C therapy in a safety net hospital: access, efficacy, and safety.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  33. LI X, Gao F, Liu H, Zhang H, et al
    Lamivudine improves short-term outcome in hepatitis B virus-related acute-on-chronic liver failure patients with a high model for end-stage liver disease score.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  34. WIJARNPREECHA K, Thongprayoon C, Ungprasert P
    Impact of caffeine in hepatitis C virus infection: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  35. WIJARNPREECHA K, Thongprayoon C, Panjawatanan P, Manatsathit W, et al
    Hepatitis B virus infection and risk of gallstones: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  36. ARDESIA M, Costantino G, Fries W
    Lower response to the hepatitis B vaccine in future inflammatory bowel disease patients.
    Eur J Gastroenterol Hepatol. 2016;28:1101-2.
    PubMed     Text format    


  37. BURLONE ME, Pedrinelli AR, Giarda P, Minisini R, et al
    Influence of age on sex-related differences among patients with hepatitis C.
    Eur J Gastroenterol Hepatol. 2016;28:1100-1.
    PubMed     Text format    


    August 2016
  38. SCHULZ M, Beha D, Plehm K, Zollner C, et al
    High prevalence of anti-hepatitis E virus antibodies in outpatients with chronic liver disease in a university medical center in Germany.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  39. LEWIS H, Kunkel J, Axten D, Dalton J, et al
    Community nurse-led initiation of antiviral therapy for chronic hepatitis C in people who inject drugs does not increase uptake of or adherence to treatment.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  40. BERT F, Rindermann A, Abdelfattah MA, Stahmeyer JT, et al
    High prevalence of chronic hepatitis B and C virus infection in a population of a German metropolitan area: a prospective survey including 10 215 patients of an interdisciplinary emergency unit.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  41. PARK CH, Kim HY, Lee SW, Song DS, et al
    On-treatment and off-treatment efficacy of entecavir in a real-life cohort of chronic hepatitis B patients.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  42. MANCEBO M, Real LM, Mira JA, Recio E, et al
    Changes in the response to treatment against chronic hepatitis C between 1999 and 2015: data from a prospective cohort.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  43. DYSON JK, Jopson L, Ng S, Lowery M, et al
    Improving testing for hepatitis B before treatment with rituximab.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  44. WANG P, Huang G, Tam N, Wu C, et al
    Influence of preoperative sodium concentration on outcome of patients with hepatitis B virus cirrhosis after liver transplantation.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  45. PIERUCKA M, Stalke P, Zagozdzon P, Smiatacz T, et al
    The prevalence and co-occurrence of hematological complications at the time of diagnosis of chronic hepatitis C in Poland: a cross-sectional study.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  46. MARCELLIN F, Fournier I, Carrieri MP, Poizot-Martin I, et al
    From first-generation hepatitis C virus protease inhibitors to direct-acting antivirals: self-reported symptoms as a warning signal for potential adverse events (ANRS HC26, ANRS HC27 trials).
    Eur J Gastroenterol Hepatol. 2016;28:733-4.
    PubMed     Text format    


    May 2016
  47. KARAKOYUN M, Ecevit CO, Kilicoglu E, Aydogdu S, et al
    Autoimmune hepatitis and long-term disease course in children in Turkey, a single-center experience.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  48. MARCELLIN F, Protopopescu C, Poizot-Martin I, Miailhes P, et al
    Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort).
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  49. WANG H, Xu H, Qu L, Wang X, et al
    Red blood cell distribution width and globulin, noninvasive indicators of fibrosis and inflammation in chronic hepatitis patients.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  50. TOSON EA, Shiha GE, El-Mezayen HA, El-Sharkawy AM, et al
    Diagnostic performance of T lymphocyte subpopulations in assessment of liver fibrosis stages in hepatitis C virus patients: simple noninvasive score.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  51. YILMAZ B, Unlu O, Evcen R, Ugurluoglu C, et al
    Acute onset seronegative autoimmune hepatitis: are simplified diagnostic criteria sufficient?
    Eur J Gastroenterol Hepatol. 2016;28:607-8.
    PubMed     Text format    


  52. ABDEL-RAZIK A, Elhelaly R, Elzehery R, El-Diasty A, et al
    Could serotonin be a potential marker for hepatocellular carcinoma? A prospective single-center observational study.
    Eur J Gastroenterol Hepatol. 2016;28:599-605.
    PubMed     Text format     Abstract available


    April 2016
  53. ZEUZEM S, Mantry P, Soriano V, Buynak RJ, et al
    Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  54. KARAGOZ E, Tanoglu A, Ulcay A, Erdem H, et al
    Mean platelet volume and red cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in patients with chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  55. LISON H, Garioud A, Halfon P, Jambon S, et al
    Cytolytic hepatitis related to simeprevir overdose in a patient with cirrhosis and HIV-HCV genotype 1 coinfection.
    Eur J Gastroenterol Hepatol. 2016;28:486-7.
    PubMed     Text format    


    March 2016
  56. GULATI R, Nawaz M, Pyrsopoulos NT
    Comparative analysis of online patient education material pertaining to hepatitis and its complications.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  57. BOTTERO J, Boyd A, Gozlan J, Carrat F, et al
    Effectiveness of hepatitis B rapid tests toward linkage-to-care: results of a randomized, multicenter study.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  58. DINTSIOS CM
    Re: Patient and physician preferences for the treatment of chronic hepatitis C virus infections: does the perspective matter? (Eur J Gastroenterol Hepatol 2015, 27:1063-1068).
    Eur J Gastroenterol Hepatol. 2016;28:362.
    PubMed     Text format    


  59. OZARAS R, Tahan V, Tabak F
    More on autoimmune hepatitis and acute hepatitis A.
    Eur J Gastroenterol Hepatol. 2016;28:360.
    PubMed     Text format    


    February 2016
  60. WASZCZUK E, Waszczuk KM, Mulak A, Paradowski L, et al
    Inadequate seroprotection against hepatitis B virus and one detected case of hepatitis C virus infection among patients with inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  61. HELAL GK, Gad MA, Abd-Ellah MF, Mahgoup EM, et al
    Coadministration of ezetimibe with pegylated interferon plus ribavirin could improve early virological response in chronic hepatitis C obese Egyptian patients.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  62. CARVALHANA SC, Leitao J, Alves AC, Bourbon M, et al
    Hepatitis B and C prevalence in Portugal: disparity between the general population and high-risk groups.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  63. CORSI DJ, Karges W, Thavorn K, Crawley AM, et al
    Influence of female sex on hepatitis C virus infection progression and treatment outcomes.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  64. NIEDERAU C, Amani A, Thiel A
    Long-term follow-up of HBsAg-positive patients in Germany.
    Eur J Gastroenterol Hepatol. 2016;28:48-56.
    PubMed     Text format     Abstract available


    December 2015
  65. HUNTER JG, Madden RG, Stone AM, Osborne N, et al
    Locally acquired hepatitis E in Cornwall, the UK; geographical clustering, environmental and social factors: a case-controlled study coastal clustering of HEV; Cornwall, UK.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  66. SELLIER PO, Schnepf N, Amarsy R, Maylin S, et al
    Hepatitis B virus status in children born to HIV/HBV coinfected women in a French hospital: a cross-sectional study.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  67. OZDEN HT
    Hepatitis A seroprevalence in patients with chronic viral hepatitis in Konya, Turkey.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  68. WANG H, Innes H, Hutchinson SJ, Goldberg DJ, et al
    The prevalence and impact of thrombocytopenia, anaemia and leucopenia on sustained virological response in patients receiving hepatitis C therapy: evidence from a large 'real world' cohort.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  69. AIZAWA Y, Abe H, Sugita T, Seki N, et al
    Centrilobular zonal necrosis as a hallmark of a distinctive subtype of autoimmune hepatitis.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  70. CHENG XP, Zhao J, Chen Y, Meng FK, et al
    Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  71. SAEZ-ROYUELA F, Linares P, Cervera LA, Almohalla C, et al
    Evaluation of advanced fibrosis measured by transient elastography after hepatitis C virus protease inhibitor-based triple therapy.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  72. ABDEL-RAZIK A, Mousa N, Abdel-Aziz M, Elhelaly R, et al
    Elevated serum alpha-fetoprotein levels in patients with chronic hepatitis C virus genotype 4: not the end of the story.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  73. LAW ST, Lee MK, Li KK, Mok CK, et al
    Comparison of efficacy and renal safety of telbivudine and entecavir in treatment-naive elderly patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  74. DETERDING K, Gruner N, Buggisch P, Galle PR, et al
    Symptoms of anxiety and depression are frequent in patients with acute hepatitis C and are not associated with disease severity.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  75. MARTIN DJ, Weideman R, Crook T, Brown G, et al
    Relationship of hepatic fibrosis, cirrhosis, and mortality with cholecystectomy in patients with hepatitis C virus infection.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


    May 2015
  76. ABDELFATTAH MR, Elsiesy H
    Reappraisal of upper age limit for adult living-donor liver transplantation using right lobe grafts: an outcome analysis.
    Eur J Gastroenterol Hepatol. 2015;27:593-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: